SAN
FRANCISCO, July 4, 2022 /PRNewswire/ -- A new market
study published by Global Industry Analysts Inc., (GIA) the premier
market research company, today released its report
titled "Stable Isotope Labeled Compounds - Global Market
Trajectory & Analytics". The report presents fresh perspectives
on opportunities and challenges in a significantly transformed post
COVID-19 marketplace.
FACTS AT A GLANCE
What's New for 2022?
- Global competitiveness and key competitor percentage market
shares
- Market presence across multiple geographies -
Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke
updates
- Access to our digital archives and MarketGlass Research
Platform
- Complimentary updates for one year
Edition: 9; Released: June 2022
Executive Pool: 692
Companies: 73 - Players covered include Alsachim;
Cambridge Isotope Laboratories, Inc.; IsoSciences - an MPD
Chemicals Company; Medical Isotopes, Inc.; Merck KgaA; Nordion
(Canada), Inc.; Omicron
Biochemicals, Inc.; PerkinElmer, Inc.; Rotem Industries Ltd.; Taiyo
Nippon Sanso Corporation; Trace Sciences International; Urenco
Limited and Others.
Coverage: All major geographies and key segments
Segments: Type (Deuterium, Oxygen-18, Carbon-13,
Nitrogen-15, Other Types); End-Use (Pharma & Biotech Companies,
Academic & Research Institutes, Hospitals & Diagnostic
Centers, Other End-Uses)
Geographies: World; United
States; Canada;
Japan; China; Europe
(France; Germany; Italy; United
Kingdom; Spain;
Russia; and Rest of Europe); Asia-Pacific (Australia; India; South
Korea; and Rest of Asia-Pacific); Latin
America (Argentina;
Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel;
Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Complimentary Project Preview - This is an ongoing
global program. Preview our research program before you make a
purchase decision. We are offering a complimentary access to
qualified executives driving strategy, business development, sales
& marketing, and product management roles at featured
companies. Previews provide deep insider access to business trends;
competitive brands; domain expert profiles; and market data
templates and much more. You may also build your own bespoke report
using our MarketGlass™ Platform which offers thousands of data
bytes without an obligation to purchase our report. Preview
Registry
ABSTRACT-
Amid the COVID-19 crisis, the global market for Stable Isotope
Labeled Compounds estimated at US$305.4
Million in the year 2022, is projected to reach a revised
size of US$356 Million by 2026,
growing at a CAGR of 3.7% over the analysis period. Deuterium, one
of the segments analyzed in the report, is projected to grow at a
4.9% CAGR, while growth in the Oxygen-18 segment is readjusted to a
revised 3.8% CAGR. Stable isotope labelling comprises the use
of non-radioactive isotopes which can act as tracers employed to
model various chemical and biochemical systems. Stable
isotope-labelled compounds gained attention in the research related
to metabolism-mediated toxicity. They have gained greater
importance in the evaluation of in vivo metabolism in various
metabolic research programs. Technologies such as NMR (nuclear
magnetic resonance) or MS (mass spectrometry) have increased the
research. These technologies have facilitated improved use of
stable isotope labelled compounds for assessing the disposition of
drugs in addition to their toxicity profile prior to their
application on patients. They are becoming instrumental in
mechanistic toxicity research, as the compounds act as a beneficial
solution to improve research related to drug delivery. Therefore,
they are critical in managing various diseases, especially diabetes
and cancer.
Stable isotope-labeled compounds include nitrogen-15, oxygen-18,
carbon-13, deuterium, and others (hydrogen ad Sulphur). Deuterium
is anticipated to drive the market, supported by the increasing
research on drugs in the pharmaceutical sector and the growing
deuterium-labeled compounds availability. Drug metabolism
researchers and toxicologists have been using deuterium-labeled
compounds for gaining insights about drug disposition and these
compounds' performance in the target organ toxicities. Aside from
their use in metabolomics research, stable isotope-labeled
compounds are finding use in medical diagnostic research,
proteomics, and environmental analysis. Mass spectrometry and NMR
can be employed for the identification of the isotope on the
molecule. 15N, 13C, and 2H are the generally employed stable
isotopes.
The stable isotope labelled compounds market is anticipated to
register healthy growth, supported by the biopharmaceutical
industry's growing research and development initiatives, rising
incidence of diseases, especially cancer, and growing research
related to proteomics. Stable isotope labeled compounds is
witnessing growing use in metabolism mediated toxicity research.
Drug toxicity research has surged in recent years for creating
effective diagnostics and therapeutics. Investments in the R&D
of pharmaceuticals are also on the rise in several emerging
markets. The market is also expected to be gain from the emergence
of NMR and MS technologies, and use in areas such as biomedical
research, clinical diagnostics, pharmaceutical research,
agricultural research, and ecological and environmental research.
MS and NMR technologies have aided in the use of stable isotopes
labeled compounds for the assessment of drugs disposition and
ascertaining the toxicity profile, prior to the use of the drugs on
patients. Also, the fast-paced industrialization, and growth of
end-use sectors are likely to benefit market growth. Furthermore,
rising research initiatives in personalized medicine is expected to
aid the market. Stable isotope-labeled compounds also have
considerable potential in the dynamic evaluation of vivo metabolism
in pediatrics. Growing focus on speeding-up the approval of novel
treatment modalities for lowering mortality and morbidity rates in
pediatric patients is boding well for the market.
Stable isotope labeled compounds typically find application in
research and academic institutes, diagnostic centres and hospitals,
and biotechnology and pharmaceutical companies, among others.
Academic and research institutes lead the market owing to
increasing research programs in environmental & ecological,
pharmaceutical, agricultural, and biomedical sectors. Use in the
biotechnology and pharmaceutical sectors is on the rise owing to
increasing R&D investments for drug research. Research and
development leads the market, due to the rising spend on such
activities. Private and government players are making increasing
investments in product development. As only a small volume of
plasma is required from one sample to review the isotope
enrichment, study of preterm infants is also possible. Several
studies are underway for metabolic outcomes and biological side
effects of the compound. However, the significant cost associated
with these compounds, and the shortage of experienced personnel for
performing biomedical and pharmaceutical research with the use of
compounds are likely to hamper market growth. The market also
witnessed supply chain disruptions during the COVID-19
pandemic.
North America and Europe account for a major share of the global
market. In North America, growth
is supported by the expansion of the biopharmaceutical and
pharmaceutical sectors, the significant nuclear industry present in
the US, developments in metabolic and nutrition research, growing
pharmaceutical industry in Canada,
and access to funding. The market in the region is expected to grow
at a strong rate due to existence of major companies, strong
healthcare infrastructure, and considerable cancer prevalence.
Also, the supportive government efforts, and growing research
partnerships are aiding market growth. The US leads the regional
market due to significant patient population, established
healthcare system, and favorable healthcare policies. In the US,
there is considerable production of stable isotope-labeled
compounds. In Canada, the rising
stable isotope-labeled compounds demand is being fostered by the
developments related to positron emission tomography method.
Asia-Pacific and China are poised to record fastest growth, on
account of increasing number of cancer cases, especially in
India and China. Also, the rising technological
developments in the healthcare space, better healthcare policies,
and improving healthcare infrastructure are all supporting the
market in the region. More
MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center
that is custom configurable to today`s busy business executive`s
intelligence needs! This influencer driven interactive research
platform is at the core of our primary research engagements and
draws from unique perspectives of participating executives
worldwide. Features include - enterprise-wide peer-to-peer
collaborations; research program previews relevant to your company;
3.4 million domain expert profiles; competitive company profiles;
interactive research modules; bespoke report generation; monitor
market trends; competitive brands; create & publish blogs &
podcasts using our primary and secondary content; track domain
events worldwide; and much more. Client companies will have
complete insider access to the project data stacks. Currently in
use by 67,000+ domain experts worldwide.
Our platform is free for qualified executives and is accessible
from our website www.StrategyR.com or via our just released mobile
application on iOS or Android
About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned
market research publisher the world`s only influencer driven market
research company. Proudly serving more than 42,000 clients from 36
countries, GIA is recognized for accurate forecasting of markets
and industries for over 33 years.
CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: ZA@StrategyR.com
LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp
Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./
Follow Us on Twitter
https://twitter.com/marketbytes
Journalists & Media
Info411@strategyr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/with-market-size-valued-at-356-million-by-2026-its-a-healthy-outlook-for-the-global-stable-isotope-labeled-compounds-market-301579530.html
SOURCE Global Industry Analysts, Inc.